HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Avelumab

HCID 178792884
New reaction
Print

Completing data — refresh the page later to see the latest

Names & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
No structure available

Names & identifiers

Preferred name
Avelumab
English name
Avelumab
Molecular weight
0

Names & synonyms

AvelumabMSB0010718CAvelumab (MSB0010718C)Avelumab (anti- PD-L1)Research Grade AvelumabAvelumab - in PBS bufferResearch Grade Avelumab(DHJ70103)Avelumab (Anti-Human PD-L1, Human Antibody)Immunoglobulin G1, anti-(human CD antigen CD274) (human monoclonal MSB0010718C heavy chain), disulfide with human monoclonal MSB0010718C light chain, dimer (ACI)

Database identifiers

CAS
1537032-82-8

Properties

Physicochemical properties

storage temp.
4 °C, · Store at 4°C, do not freeze
solubility
Soluble in DMSO
form
Liquid
color
Colorless to light yellow
FDA UNII
2 PJ551I · KXG2PJ551I
NCI Dictionary of Cancer Terms
avelumab
NCI Drug Dictionary
avelumab
ATC code
1 XC31 · L01XC31

Chemistry & industry

Applications

UsesAvelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes